Peroxisome proliferator-activated receptor α (PPARα) and agonist inhibit cholesterol 7α-hydroxylase gene (CYP7A1) transcription

Journal of Lipid Research

Volumn 41, Issue 4, 2000, Pages 514-520

  Marrapodi, Maria ^a   Chiang, John Y L ^a  

^a Northeastern Ohio Medical University   (United States)

Author keywords

Bile acid synthesis; Cytochrome P450; Gallstones; HNF 4; Hypolipidemic drugs; Peroxisome proliferators

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; COMPLEMENTARY DNA; CYTOCHROME P450; FIBRIC ACID DERIVATIVE; NUCLEAR FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID; RETINOID X RECEPTOR;

ANIMAL CELL; ARTICLE; BILE ACID SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GALLSTONE; GENETIC TRANSCRIPTION; HEPATOMA CELL; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BINDING SITES; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CLOFIBRIC ACID; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LIVER; MODELS, GENETIC; PEROXISOME PROLIFERATORS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PYRIMIDINES; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; REGULATORY SEQUENCES, NUCLEIC ACID; RESPONSE ELEMENTS; RETINOID X RECEPTORS; SPECIES SPECIFICITY; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0033999108     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Fruchart, J. C., H. B. Brewer, Jr., and E. Leitersdorf. 1998. Consensus for the use of fibrates in the treatment of dyslipoproteinemia and corollary heart disease. Fibrate Consensus. Am. J. Cardiol. 81: 912-917.
2. Stael, B., J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, and J. C. Fruchart. 1998. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 98: 2088-2093.
3. Forman, B. M., J. Chen, and R. M. Evans. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc. Natl. Acad. Sci. USA. 94: 4312-4317.
4. Schoonjans, K., B. Staels, and J. Auwerx. 1996. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37: 907-925.
5. Peters, J. M., N. Hennuyer, B. Stales, J-C. Fruchart, C. Fievet, F. J. Gonzalez, and J. Auwerx. 1997. Alterations in lipoprotein metaboism in peroxisome proliferator-activated receptor α-deficient mice. J. Biol. Chem. 272: 27307-27312.
6. Costet, P., C. Legendre, J. More, A. Edgar, P. Galtier, and T. Pineau. 1998. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J. Biol. Chem. 273: 29577-29585.
7. Lee, S., T. Pineau, J. Drago, E. Lee, J. Owens, D. Kroetz, P. Fernandez-Salguero, H. Westphal, and F. Gonzalez. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisime proliferators. Mol. Cell. Biol. 15: 3012-3022.
8. Einarsson, K., and B. Angelin. 1986. Hyperlipoproteinemia, hypolipidemic treatment, and gallstone disease. Atheroscler. Rev. 15: 67-97.
9. Chiang, J. Y. L. 1998. Regulation of bile acid synthesis. Front. Biosci. 3: D176-D193.
10. Pandak, W. M., Y. C. Li, J. Y. L. Chiang, E. L. Studer, E. C. Gurley, D. M. Heuman, Z. R. Vlahcevic, and P. B. Hylemon. 1991. Regulation of cholesterol 7α-hydroxylase mRNA and transcriptional activity by taurocholate and cholestetol in the chronic biliary diverted rat. J. Biol. Chem. 266: 3416-3421.
11. Wang, D. P., D. Stroup, M. Marrapodi, M. Crestani, G. Galli, and J. Y. L. Chiang. 1996. Transcriptional regulation of the human cholesterol 7α-hydroxylase gene (CYPZA) in HepG2 cells, J. Lipid Res. 37: 1831-1841.
12. Stahlberg, D., B. Angelin, and K. Einarsson. 1989. Effects of treatment with clofibrate, bezafibrate, and ciprofibrale on the metabolism of cholesterol in rat liver microsomes. J. Lipid Res. 30: 953-958.
13. Stahlberg, D., E. Reihner, M. Rudling, L. Berglund, K. Einarsson, and B. Angelin. 1995. Influence of bezafibrate on hepatic cholesterol metabolisrn in gallstone patients: reduced activity of cholesterol 7alpha-hydroxylase. Hepatology. 21: 1025-1230.
14. Bertolotti, M., M. Concari, P. Loria, N. Abate, A. Pinetti, M. E. Guicciardi, and N. Carulli. 1995. Effects of different phenotypes of hyperlipoproteinemia and of treatment with fibric acid derivatives on the rates of cholesterol 7alpha-hydroxylation in humans. Arterioscler. Thromb. Vasc. Biol. 15: 1064-1069.
15. Odman, B., S. Ericsson, M. Lindmark, L. Berglund, and B. Angelin. 1991. Gemfibrozil in familial combined hyperlipidaemia: effect of added low-dose cholestyramine on plasma and biliary lipids. Eur. J. Clin. Invest. 21: 344-349.
16. Crestani, M., A. Sadeghpour, D. Stroup, G. Gali, and J. Y. L. Chiang. 1998. Transcriptional activation of the cholesterol 7α-hydroxylase gene (CYP7A) by nuclear hormone receptors. J. Lipid Res. 39: 2192-2200.
17. Cooper, A. D., J. Chen, M. J. Botelho-Yetkinler, Y. Cao, T. Taniguchi, and B. Levy-Wilson. 1997. Characterization of hepatic-specific regulatory elements in the promoter region of the human cholesterol 7α-hydroxylase gene. J. Biol. Chem. 272: 3444-3452.
18. Jiang, G., L. Nepomuceno, K. Hopkins, and F. M. Sladek. 1995. Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol. Cell. Biol. 15: 5131-5143.
19. Stroup, D., M. Crestani, and J. Y. L. Chiang. 1997. Identification of a bile acid response element in the choleslerol 7α-hydroxylase gene (CYP7A). Am. J. Physiol. 273:G508-G517.
20. Makishima, M., A. Y. Okamoto, J. J. Repa, H. Tu, R. M. Learned, A. Luk, M. V. Hull, K. D. Lustig, D. J. Mangelsdorf, and B. Shan. 1999. Identification of a nuclear receptor for bile acids. Science. 284: 1362-1365.
21. Parks, D. J., S. G. Blanchard, R. K. Bledsoe, G. Chandra, T. G. Consler, S. A. Kliewer, J. B. Stimmel, T. M. Willson, A. M. Zavacki, D. D. Moore, and J. M. Lehmann. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science. 284: 1365-1368.
22. Wang, H., J. Chen, K. Hollister, L. C. Sowers, and B. M. Forman. 1999. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell. 3: 543-553.
23. Chiang, J. Y. L., D. Stroup, M. Crestani, and A. Sadeghpour. 1999. Transcriptional regulation of the cholesterol 7α-hydroxylase gene (CYP7A) by nuclear hormone receptor bound to the bile acid response elements (BARE). In Bile Acids and Cholestasis. G. Paumgartner, A. Stiehl, W. Gerok, D. Keppler, and U. Leuschner, editors. Kluwer Academic Publishers, Norwell, MA. 51-58.
24. Osumi, T., N. Ishii, S. Miyazawa, and T. Hashimoto. 1987. Isolation and structural characterization of the rat acyl-CoA oxidase gene. J. Biol. Chem. 262: 8138-8143.
25. Crestani, M., D. Stroup, and J. Y. L. Chiang. 1995. Hormonal regulation of the cholesterol 7α-hydroxylase gene (CYP7A). J. Lipid Res. 36: 2419-2432.
26. Dent, C. D., and D. S. Latchman. 1993. Transcription Factors: a Practical Approach. IRI Press at Oxford University Press, New York, NY.
27. Nakshatri, H., and P. Bhat-Nakshatri. 1998. Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-I, PPAR, RAR and RXR through common response elements. Nucleic Acids Res. 26: 2491-2499.
28. Stroup, D., and J. Y. L. Chiang. 2000. HNF4 and COUP-TFII interact to modulate transcription of the choleslerol 7α-hydroxylase gene (CYP7A). J. Lipid Res. 41: 1-11.
29. DiRenzo, J., M. Soderstrom, R. Kurokawa, M. H. Ogliastro, M. Ricote, S. Ingrey, A. Horlein, M. G. Rosenfeld, and C. K. Glass. 1997. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepresors. Mol. Cell. Biol. 17: 2166-2176.
30. Hertz, R., J. Bishara-Shieban, and J. Bar-Tana. 1995. Mode of artion of peroxisome proliferators as hypolipidemic drugs. J. Biol. Chem. 270: 13470-13475.
31. Hertz, R., M. Seckbach, M. M. Zakin, and J. Bar-Tana. 1996. Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators. J. Biol. Chem. 271: 218-224.
32. Vu-Dac, N., S. Chopin-Delannoy, P. Gervois, E. Bonnelye, G. Martin, J. G. Fruchart, V. Laudet, and B. Staels. 1998. The nuclear receptors peroxisome proliferator-activated receptor alpha and Reverbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J. Biol Chem. 273: 25713-25720.
33. Sladek, F. M. R. G. 1994. Transcriptional Regulation of Liver-Specific Genes. Landes Co., Austin, TX. 207-223.